SpyGlass Pharma is pursuing a $100 million IPO to advance its glaucoma drug delivery platform through Phase 3 trials. Read ...

Clear Street Group Inc. has produced rapid top-line growth, expanding margins, and robust free cash flow ahead of its planned ...

Global CFO Richard Shin discusses separating Jollibee Foods Corporation's international unit and listing it in the U.S.

In a very unsurprising turn of events, Trump walked back his latest EU tariff threats—much to the market's delight.

Roth Capital Markets analyst Rohit Kulkarni reiterated a “Buy” rating on RedCloud Holdings in a Jan. 20 report and raised his ...

Westgold Resources Limited (ASX: WGX) (TSX: WGX) (Westgold or the Company) is pleased to report results for the period ending 31 December 2025 (Q2 FY26), with record gold production, higher volume ...

IPO; Increased inventory to support robust year-over-year growth with expected 2026 revenues of $140 to $145 million Wilmington, NC, Jan. 20, 2026 (GLOBE ...

Insilico Medicine and Hygtia Therapeutics, an incubatee of Shenzhen Pengfu Fund of Fosun Health Capital and Fosun Pharma, have entered into an exclusive license and ...